191 related articles for article (PubMed ID: 29100235)
1. Origin of Uterine Fibroids: Conversion of Myometrial Stem Cells to Tumor-Initiating Cells.
Elkafas H; Qiwei Y; Al-Hendy A
Semin Reprod Med; 2017 Nov; 35(6):481-486. PubMed ID: 29100235
[No Abstract] [Full Text] [Related]
2. Overexpression of the truncated form of High Mobility Group A proteins (HMGA2) in human myometrial cells induces leiomyoma-like tissue formation.
Mas A; Cervelló I; Fernández-Álvarez A; Faus A; Díaz A; Burgués O; Casado M; Simón C
Mol Hum Reprod; 2015 Apr; 21(4):330-8. PubMed ID: 25542836
[TBL] [Abstract][Full Text] [Related]
3. Activin A in Inflammation, Tissue Repair, and Fibrosis: Possible Role as Inflammatory and Fibrotic Mediator of Uterine Fibroid Development and Growth.
Protic O; Islam MS; Greco S; Giannubilo SR; Lamanna P; Petraglia F; Ciavattini A; Castellucci M; Hinz B; Ciarmela P
Semin Reprod Med; 2017 Nov; 35(6):499-509. PubMed ID: 29100238
[No Abstract] [Full Text] [Related]
4. Endocrine disruptor exposure during development increases incidence of uterine fibroids by altering DNA repair in myometrial stem cells.
Prusinski Fernung LE; Yang Q; Sakamuro D; Kumari A; Mas A; Al-Hendy A
Biol Reprod; 2018 Oct; 99(4):735-748. PubMed ID: 29688260
[TBL] [Abstract][Full Text] [Related]
5. Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth.
Ono M; Yin P; Navarro A; Moravek MB; Coon JS; Druschitz SA; Serna VA; Qiang W; Brooks DC; Malpani SS; Ma J; Ercan CM; Mittal N; Monsivais D; Dyson MT; Yemelyanov A; Maruyama T; Chakravarti D; Kim JJ; Kurita T; Gottardi CJ; Bulun SE
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17053-8. PubMed ID: 24082114
[TBL] [Abstract][Full Text] [Related]
6. An endocrine-disrupting chemical, fenvalerate, induces cell cycle progression and collagen type I expression in human uterine leiomyoma and myometrial cells.
Gao X; Yu L; Castro L; Moore AB; Hermon T; Bortner C; Sifre M; Dixon D
Toxicol Lett; 2010 Jul; 196(3):133-41. PubMed ID: 20230880
[TBL] [Abstract][Full Text] [Related]
7. Endocrine-disrupting chemicals and uterine fibroids.
Katz TA; Yang Q; Treviño LS; Walker CL; Al-Hendy A
Fertil Steril; 2016 Sep; 106(4):967-77. PubMed ID: 27553264
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression and regulation of NR2F2 and CTNNB1 in uterine fibroids.
Zaitseva M; Holdsworth-Carson SJ; Waldrip L; Nevzorova J; Martelotto L; Vollenhoven BJ; Rogers PA
Reproduction; 2013 Aug; 146(2):91-102. PubMed ID: 23704310
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease.
Laganà AS; Vergara D; Favilli A; La Rosa VL; Tinelli A; Gerli S; Noventa M; Vitagliano A; Triolo O; Rapisarda AMC; Vitale SG
Arch Gynecol Obstet; 2017 Nov; 296(5):855-867. PubMed ID: 28875276
[TBL] [Abstract][Full Text] [Related]
10. Developmental Exposure to Endocrine Disruptors Expands Murine Myometrial Stem Cell Compartment as a Prerequisite to Leiomyoma Tumorigenesis.
Mas A; Stone L; O'Connor PM; Yang Q; Kleven D; Simon C; Walker CL; Al-Hendy A
Stem Cells; 2017 Mar; 35(3):666-678. PubMed ID: 27739139
[TBL] [Abstract][Full Text] [Related]
11. Expression of mucin-1, galectin-1 and galectin-3 in human leiomyosarcoma in comparison to leiomyoma and myometrium.
Weissenbacher T; Kuhn C; Mayr D; Pavlik R; Friese K; Scholz C; Jeschke U; Ditsch N; Dian D
Anticancer Res; 2011 Feb; 31(2):451-7. PubMed ID: 21378323
[TBL] [Abstract][Full Text] [Related]
12. Role of stem cells in human uterine leiomyoma growth.
Ono M; Qiang W; Serna VA; Yin P; Coon JS; Navarro A; Monsivais D; Kakinuma T; Dyson M; Druschitz S; Unno K; Kurita T; Bulun SE
PLoS One; 2012; 7(5):e36935. PubMed ID: 22570742
[TBL] [Abstract][Full Text] [Related]
13. Relative overexpression of the parathyroid hormone-related protein gene in human leiomyomas.
Weir EC; Goad DL; Daifotis AG; Burtis WJ; Dreyer BE; Nowak RA
J Clin Endocrinol Metab; 1994 Mar; 78(3):784-9. PubMed ID: 8126157
[TBL] [Abstract][Full Text] [Related]
14. Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3.
Joseph DS; Malik M; Nurudeen S; Catherino WH
Fertil Steril; 2010 Mar; 93(5):1500-8. PubMed ID: 19328471
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of phthalate esters in human myometrial and leiomyoma cells and increased urinary level of phthalate metabolite in women with uterine leiomyoma.
Kim JH; Kim SH; Oh YS; Ihm HJ; Chae HD; Kim CH; Kang BM
Fertil Steril; 2017 Apr; 107(4):1061-1069.e1. PubMed ID: 28292620
[TBL] [Abstract][Full Text] [Related]
16. Human uterine leiomyoma stem/progenitor cells expressing CD34 and CD49b initiate tumors in vivo.
Yin P; Ono M; Moravek MB; Coon JS; Navarro A; Monsivais D; Dyson MT; Druschitz SA; Malpani SS; Serna VA; Qiang W; Chakravarti D; Kim JJ; Bulun SE
J Clin Endocrinol Metab; 2015 Apr; 100(4):E601-6. PubMed ID: 25658015
[TBL] [Abstract][Full Text] [Related]
17. Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells.
Sant'Anna GDS; Brum IS; Branchini G; Pizzolato LS; Capp E; Corleta HVE
Gynecol Endocrinol; 2017 Aug; 33(8):629-633. PubMed ID: 28300476
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma.
Cardozo ER; Foster R; Karmon AE; Lee AE; Gatune LW; Rueda BR; Styer AK
Reprod Biol Endocrinol; 2018 May; 16(1):46. PubMed ID: 29747655
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth interacting factor expression in leiomyoma compared with myometrium.
Yen-Ping Ho J; Man WC; Wen Y; Polan ML; Shih-Chu Ho E; Chen B
Fertil Steril; 2010 Aug; 94(3):1078-83. PubMed ID: 19524896
[TBL] [Abstract][Full Text] [Related]
20. High expression of cyclooxygenase-2 in uterine fibroids and its correlation with cell proliferation.
Ke X; Dou F; Cheng Z; Dai H; Zhang W; Qu X; Ding P; Zuo X
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):199-203. PubMed ID: 23398724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
